DEBANANDA PATI to Dose-Response Relationship, Drug
This is a "connection" page, showing publications DEBANANDA PATI has written about Dose-Response Relationship, Drug.
Connection Strength
0.039
-
Inhibition of zinc-induced metallothionein mRNA accumulation by gonadotropin-releasing hormone in human hepatocarcinoma cell line HepG2. Eur J Biochem. 1996 Nov 15; 242(1):36-40.
Score: 0.026
-
A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group study. Clin Cancer Res. 2007 Mar 01; 13(5):1516-22.
Score: 0.013